1. Home

Multiple sclerosis drug recalled over unacceptable 'variability'

 
• By Costanza Potter

A manufacturer has recalled a medicine used to treat multiple sclerosis (MS) “as a precautionary measure”, the pharmacy negotiator has announced.

Multiple sclerosis
It advised pharmacists to stop supplying the affected batches “immediately”

Community Pharmacy England (CPE) yesterday (August 19) said that four batches of Fingolimod 0.5 mg hard capsules have been recalled by their manufacturer Glenmark Pharmaceuticals Europe Ltd.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Costanza Potter

Read more by Costanza Potter

Cos Potter joined C+D as its news editor in December 2022 but has been covering primary care news for over five years. After starting out at the pharmacy press in 2019, she worked at a GP title for several years before the pharmacy sector beckoned her back.

Latest from News

More from Clinical